Pharmacologic reversion of epigenetic silencing of the PRKD1promoter blocks breast tumor cell invasion and metastasis

Sahra Borgés(Mayo Clinic in Florida), Peter Störz(Mayo Clinic in Florida)
Breast Cancer Research
August 23, 2013
Cited by 87


Related Papers